AusPAR: Atezolizumab

Australian Public Assessment Report

AusPAR

Australian Public Assessment Report for Atezolizumab [PDF, 1.34 MB]

Australian Public Assessment Report for Atezolizumab [Word, 2.06 MB]

Attachment: Product Information: Atezolizumab [PDF, 378.39 KB]

Attachment: Product Information: Atezolizumab [Word, 458.08 KB]

Attachment: Extract from Clinical Evaluation: Atezolizumab [PDF, 6.39 MB]

Attachment: Extract from Clinical Evaluation: Atezolizumab [Word, 13.6 MB]

Device/Product Name

Tecentriq

Active ingredients

Atezolizumab

AusPAR Date

3 September 2018

Published

3 October 2018

Submission Number

PM-2016-02087-1-4

Submission Type

New biological entity

Decision

Approved